Together, our results reveal a role for FLI1 in regulating WAS/WIP and megakaryopoiesis, with direct mechanistic and therapeutic implications for microthrombocytopenia in WAS patients. The gene discussed is WIPF1; the disease is Wiskott-Aldrich syndrome.